0001437749-17-018143.txt : 20171102 0001437749-17-018143.hdr.sgml : 20171102 20171102160242 ACCESSION NUMBER: 0001437749-17-018143 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171030 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20171102 DATE AS OF CHANGE: 20171102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CTD HOLDINGS INC CENTRAL INDEX KEY: 0000922247 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 593029743 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-25466 FILM NUMBER: 171172193 BUSINESS ADDRESS: STREET 1: 14120 NW 126TH TERRACE CITY: ALACHUA STATE: FL ZIP: 32615-4816 BUSINESS PHONE: 386-418-8060 MAIL ADDRESS: STREET 1: 14120 NW 126TH TERRACE CITY: ALACHUA STATE: FL ZIP: 32615-4816 FORMER COMPANY: FORMER CONFORMED NAME: CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC DATE OF NAME CHANGE: 19941012 8-K 1 ctdh20171102_8k.htm FORM 8-K ctdh20171102_8k.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)      October 30, 2017          

 


CTD HOLDINGS, INC.

(Exact name of registrant as specified in charter)

 

Florida   000-25466   59-3029743
(State or other Jurisdiction of Incorporation or Organization)   (Commission File Number)   (IRS Employer Identification No.)

 

 

6714 NW 16th Street, Suite B, Gainesville, Florida 32563

32563

 

  (Address of Principal Executive Offices) (zip code)  

 

            386-418-8060            

(Registrant’s telephone
number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:

 

  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

  Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company 
 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On October 30, 2017, the Board of Directors of CTD Holdings, Inc. (the “Company”) approved an increase in the annual base salary of Jeffrey L. Tate, the Company’s Chief Operating Officer and Chief Scientific Officer, from $152,000 to $177,000.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

CTD Holdings, Inc.

 

Date: November 2, 2017

 

By: /s/ N. Scott Fine        

N. Scott Fine

Chief Executive Officer